🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 28106W103
- Market Cap
- Mid Cap
- IPO
- 2/2/2016 · $16.00/share
Business: Editas Medicine, Inc. is a leading genome editing company dedicated to treating patients with genetically defined diseases by correcting their disease-causing genes. The company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.
Company Contact
- CEO
- Gilmore O'Neill
- CFO
- Amy Parison
- Headquarters
- 11 Hurley Streetr, Cambridge, MA, 02141
- Phone
- 617-401-9000
- Investor Relations
- 212-362-1200 · ir@editasmed.com